Categories Analysis, Other Industries

Earnings Preview: Can KB Home (KBH) navigate short-term challenges in Q4?

Market watchers forecast a decline in earnings and revenues for the November quarter

KB Home (NYSE: KBH) will be publishing fourth-quarter earnings on January 10, after markets close. Of late, the homebuilder has been facing headwinds from inflation and high mortgage rates, but it looks poised to deliver better performance in fiscal 2024 amid steady improvement in orders.

The company’s stock made impressive gains in the final weeks of 2023, after experiencing weakness since mid-year. The value has increased by more than 75% in the past twelve months.

It is estimated that orders will continue to recover due to the shortage of homes and demographic tailwinds. In recent quarters, the company’s key financial metrics exceeded expectations, thanks to improved build times and lower selling prices. On the flip side, the dip in prices puts pressure on margins. It is worth noting that revenues of the core homebuilding segment declined by double digits in Q3. There is speculation that prices will bounce back in the final months of the year when a shift toward higher-price deliveries is expected to happen.

What’s in Cards

KB Home offers mortgage concessions to customers, wherever required, to drive sales. Such initiatives, combined with lower prices, have reduced cancellations, and the trend is expected to continue. The flexibility and affordability offered by the company’s built-to-order model should position it to navigate the challenges in the housing market.

KB Home’s fourth-quarter report is slated for release on January 10, after regular trading hours. On average, analysts following the company forecast earnings of $1.70 per share, compared to $2.47 per share in the comparable period of 2022. The year-over-year decline reflects an estimated 17% fall in Q4 revenues to $1.62 billion.

From KB Home’s Q3 2023 earnings call:

“Although KB Home is perceived to be a California builder, our business is becoming more diversified and we like the balance of our geographic footprint. Our Southeast region has grown into a larger business, approaching 20% of our revenues this year as compared to only 11% five years ago. This region has significantly improved its profitability and returns over this timeframe, and we look forward to its continued growth.”

Mixed Outcome

In Q3, earnings and sales beat estimates for the third consecutive quarter, though overall performance came under pressure from the slowdown in orders. The company generated net orders of 2,142 for the quarter, which is down 49% year-over-year but better than the 50-60% fall expected. As a result, Q3 revenues declined 14% from last year to $1.59 billion. Net income and earnings per share decreased by 41% and 37% to $150 million and $1.80, respectively.

Over the past two months, shares of KBH stayed above their 52-week average, after recovering from a six-month low. The stock traded slightly higher on Thursday afternoon after opening lower.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025

For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model

Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer

Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third

Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance

Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top